Permixon


Indications and Reactions:

Role Indications Reactions
Secondary
Product Used For Unknown Indication 32.6%
Parkinson's Disease 8.5%
Drug Use For Unknown Indication 7.9%
Hypertension 7.9%
Benign Prostatic Hyperplasia 5.9%
Multiple Drug Overdose Intentional 4.1%
Lung Infection 3.5%
Micturition Disorder 3.5%
Type 2 Diabetes Mellitus 3.5%
Insomnia 2.9%
Pain 2.6%
Pulmonary Embolism 2.3%
Atrial Fibrillation 2.1%
Hypercholesterolaemia 2.1%
Suicide Attempt 2.1%
Bronchitis 1.8%
Essential Hypertension 1.8%
Respiratory Tract Infection 1.8%
Rhinitis Allergic 1.8%
Prostatic Adenoma 1.5%
Cerebral Haematoma 8.1%
Hepatitis 8.1%
Renal Failure 8.1%
Vomiting 8.1%
Lung Disorder 6.8%
Pupils Unequal 6.8%
Eczema 5.4%
Pulmonary Fibrosis 5.4%
Rash Maculo-papular 5.4%
Hypercalcaemia 4.1%
Hyperhidrosis 4.1%
Multiple Drug Overdose Intentional 4.1%
Orthostatic Hypotension 4.1%
Pancytopenia 4.1%
Pitting Oedema 4.1%
Cerebral Haemorrhage 2.7%
Drug Rash With Eosinophilia And Systemic Symptoms 2.7%
Hepatitis Fulminant 2.7%
Night Sweats 2.7%
Skin Necrosis 2.7%
Concomitant
Product Used For Unknown Indication 28.8%
Drug Use For Unknown Indication 12.5%
Hypertension 11.8%
Atrial Fibrillation 5.8%
Benign Prostatic Hyperplasia 5.6%
Pain 3.5%
Non-small Cell Lung Cancer Stage Iv 2.9%
Bronchitis 2.7%
Type 2 Diabetes Mellitus 2.7%
Prophylaxis 2.6%
Prostatic Adenoma 2.4%
Unevaluable Event 2.4%
Hypercholesterolaemia 2.3%
Arrhythmia 2.0%
Chronic Lymphocytic Leukaemia 2.0%
Hepatitis C 2.0%
Prostate Cancer 2.0%
Thrombosis Prophylaxis 2.0%
Depression 1.9%
Anxiety 1.8%
Renal Failure Acute 16.7%
Hyponatraemia 8.8%
Somnolence 7.9%
Tachycardia 5.3%
Thrombocytopenia 5.3%
Vomiting 5.3%
Cytolytic Hepatitis 4.4%
Pyrexia 4.4%
Renal Failure 4.4%
Weight Decreased 4.4%
Erythema 3.5%
Lung Disorder 3.5%
Respiratory Disorder 3.5%
Retinal Pigment Epithelial Tear 3.5%
Septic Shock 3.5%
Thrombosis 3.5%
Tuberculosis Bladder 3.5%
Urticaria 3.5%
Asthenia 2.6%
Decreased Appetite 2.6%

Drug Data